论文信息 - Hyper‐CVAD plus ofatumumab versus hyper‐CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome–negative acute lymphoblastic leukemia: A propensity score analysis - 字舞流文

Hyper‐CVAD plus ofatumumab versus hyper‐CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome–negative acute lymphoblastic leukemia: A propensity score analysis

M. Konopleva | H. Kantarjian | G. Garcia-Manero | F. Ravandi | Koichi Takahashi | E. Jabbour | S. O'brien | J. Khoury | N. Jain | N. Short | J. Jorgensen | Sa A. Wang | R. Champlin | Kiyomi Morita | P. Kebriaei | I. Khouri | K. Sasaki | R. Garris | Maria R. Khouri | Heather M Schroeder | Rebecca E. Garris